GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,237,000 | -0.4% | 97,327 | -0.4% | 0.10% | +12.9% |
| Q1 2022 | $4,255,000 | +11.9% | 97,686 | +13.3% | 0.08% | +10.4% |
| Q4 2021 | $3,801,000 | +1.3% | 86,196 | -12.2% | 0.08% | +5.5% |
| Q3 2021 | $3,753,000 | +22.9% | 98,211 | +28.1% | 0.07% | +1.4% |
| Q2 2021 | $3,053,000 | +18.0% | 76,664 | +5.8% | 0.07% | +1.4% |
| Q1 2021 | $2,587,000 | +6.5% | 72,474 | +9.8% | 0.07% | -9.0% |
| Q4 2020 | $2,429,000 | +38.8% | 65,998 | +41.9% | 0.08% | +18.2% |
| Q3 2020 | $1,750,000 | +39.4% | 46,502 | +51.1% | 0.07% | +22.2% |
| Q2 2020 | $1,255,000 | +10.0% | 30,779 | +2.2% | 0.05% | -11.5% |
| Q1 2020 | $1,141,000 | -56.0% | 30,109 | -45.5% | 0.06% | -45.0% |
| Q4 2019 | $2,592,000 | +8.1% | 55,210 | -1.6% | 0.11% | +4.7% |
| Q3 2019 | $2,398,000 | +17.4% | 56,081 | +9.6% | 0.11% | +16.5% |
| Q2 2019 | $2,042,000 | -2.3% | 51,160 | +2.2% | 0.09% | -12.5% |
| Q1 2019 | $2,091,000 | +225.2% | 50,068 | +197.4% | 0.10% | +173.7% |
| Q4 2018 | $643,000 | +18.4% | 16,833 | +23.5% | 0.04% | +40.7% |
| Q3 2018 | $543,000 | +159.8% | 13,628 | +158.2% | 0.03% | +125.0% |
| Q2 2018 | $209,000 | -21.7% | 5,278 | -22.9% | 0.01% | -25.0% |
| Q1 2018 | $267,000 | +15.6% | 6,850 | +6.1% | 0.02% | +14.3% |
| Q4 2017 | $231,000 | -2.5% | 6,459 | +9.0% | 0.01% | 0.0% |
| Q3 2017 | $237,000 | -64.7% | 5,924 | -62.1% | 0.01% | -66.7% |
| Q2 2017 | $672,000 | +2.9% | 15,612 | -0.1% | 0.04% | -4.5% |
| Q1 2017 | $653,000 | +75.5% | 15,624 | +62.5% | 0.04% | +57.1% |
| Q4 2016 | $372,000 | -4.9% | 9,613 | +5.8% | 0.03% | -6.7% |
| Q3 2016 | $391,000 | -3.9% | 9,085 | -3.8% | 0.03% | -6.2% |
| Q2 2016 | $407,000 | +11.5% | 9,445 | +5.1% | 0.03% | +3.2% |
| Q1 2016 | $365,000 | -49.7% | 8,989 | -50.2% | 0.03% | -49.2% |
| Q4 2015 | $726,000 | -0.7% | 18,042 | -5.4% | 0.06% | -12.9% |
| Q3 2015 | $731,000 | -2.7% | 19,079 | +5.6% | 0.07% | +9.4% |
| Q2 2015 | $751,000 | +3.0% | 18,071 | +14.3% | 0.06% | -4.5% |
| Q1 2015 | $729,000 | +68.0% | 15,815 | +55.5% | 0.07% | +59.5% |
| Q4 2014 | $434,000 | +59.0% | 10,168 | +71.8% | 0.04% | +100.0% |
| Q3 2014 | $273,000 | -10.2% | 5,917 | +3.9% | 0.02% | -38.2% |
| Q2 2014 | $304,000 | +42.1% | 5,695 | +43.5% | 0.03% | +17.2% |
| Q1 2014 | $214,000 | – | 3,969 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |